Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Reexamination Certificate
2005-11-01
2005-11-01
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
C536S054000, C536S059000
Reexamination Certificate
active
06960344
ABSTRACT:
The present invention relates to polysaccharide conjugates that comprise: a polysaccharide that binds to surface-receptors present on Antigen Presenting Cells, conjugated to one or more compounds having stable carbonyl groups covalently attached, either directly or via a bifunctional linker. The conjugates are useful as immuno-stimulants and adjuvants.
REFERENCES:
patent: 3236792 (1966-02-01), Curtis
patent: 3297604 (1967-01-01), Germino
patent: 4003792 (1977-01-01), Mill et al.
patent: 4063016 (1977-12-01), Austin
patent: 4115305 (1978-09-01), Hornby et al.
patent: 4424346 (1984-01-01), Hall et al.
patent: 4613665 (1986-09-01), Larm
patent: 4663448 (1987-05-01), Chiu
patent: 4675394 (1987-06-01), Solarek et al.
patent: 4693891 (1987-09-01), Collins et al.
patent: 4695624 (1987-09-01), Marburg et al.
patent: 4698387 (1987-10-01), Schmidt et al.
patent: 4703116 (1987-10-01), Solarek et al.
patent: 4731162 (1988-03-01), Solarek et al.
patent: 4741804 (1988-05-01), Solarek et al.
patent: 4749800 (1988-06-01), Jobe et al.
patent: 4771127 (1988-09-01), Cryz et al.
patent: 4795745 (1989-01-01), Larm et al.
patent: 4801699 (1989-01-01), Jobe et al.
patent: 4804769 (1989-02-01), Solarek et al.
patent: 4895724 (1990-01-01), Cardinal et al.
patent: 4983748 (1991-01-01), Tsai et al.
patent: 5032401 (1991-07-01), Jamas et al.
patent: 5057503 (1991-10-01), Czop et al.
patent: 5110909 (1992-05-01), Dellacherie et al.
patent: 5169840 (1992-12-01), Otterlei et al.
patent: 5508310 (1996-04-01), Rhodes
patent: 5554386 (1996-09-01), Groman et al.
patent: 5567685 (1996-10-01), Linden et al.
patent: 5583112 (1996-12-01), Kensil et al.
patent: 5591771 (1997-01-01), Markonius
patent: 5622939 (1997-04-01), Jamas et al.
patent: 5624914 (1997-04-01), Patel et al.
patent: 5668193 (1997-09-01), Gouda et al.
patent: 5738855 (1998-04-01), Szu et al.
patent: 5747475 (1998-05-01), Nordquist et al.
patent: 5785975 (1998-07-01), Parikh
patent: 5912000 (1999-06-01), Podolski et al.
patent: 5929049 (1999-07-01), Singh et al.
patent: 5989552 (1999-11-01), McKenzie et al.
patent: 6120777 (2000-09-01), Thiele et al.
patent: 8202708 (1983-12-01), None
patent: 0 320 942 (1989-06-01), None
patent: 0 326 111 (1989-08-01), None
patent: 0 477 508 (1992-04-01), None
patent: 60-051702 (1985-03-01), None
patent: 06-166635 (1994-06-01), None
patent: WO 96/20012 (1996-07-01), None
patent: WO 97/33612 (1997-09-01), None
patent: WO 99/07744 (1999-02-01), None
Ambrosino, D.M., et al., “Effect ofHaemophilus influenzaePolysaccharide Outer Membrane Protein Complex Conjugate Vaccine on Macrophaes,”J. Immunol.149:3978-3983, The American Association of Immunologists (1992).
Bogwald, J., et al., “Coupling of polysaccharides activated by means of chloroacetaldehyde dimethyl acetyl to amines or proteins by reductive amination,”Carbohydrate Res. 148:101-107, Elsevier Science Publishers B.V. (1986).
Chang, R-C., and Shaw, J-F., “The immobilization ofCandida cylinracealipase on PVC, chitin an agarose, ” Bot. Bull. Acad. Sinica (Taiwan) 28:33-42, Taipei Academic Sinica. Institute of Botany (1987).
Cryz. Jr., S.J., et al., “Pseudomonas aeruginosaImmunotype 5 Polysaccharide-Toxin A Conjugate Vaccine,”Infect. Immun. 52:161-165, American Society for Microbiology (1986).
Cryz, Jr., S.J., et al., “Pseudomonas aeruginosaPolysaccharide-Tetanus Toxoid Conjugate Vaccine: Safety and Immunogenicity in Humans,”J. Infect. Dis. 154:682-688, The University of Chicago (1986).
Cryz, Jr., S.J., et al., “Vaccine Potential ofPseudomonas aeruginosaO-Polysaccharide-Toxin A Conjugates,”Infect. Immun. 55:1547-1551, American Society for Microbiology (1987).
Cryz Jr., S.J., et al., “OctavalentPseudomonas aeruginosaO-polysaccharide-toxin A conjugate vaccine,”Microb. Pathog. 6:75-80, Academic Press, Ltd. (1989).
Cui, H., et al., “Cyclodextrin glucotransferase immobilized on konjac glucomannan,”Tiaran Chanwu Yanjiu Yu Kaifa 5:48-54, Chengtu Chin Int. Book Trading Corp. (1993).
Dellacherie, E., and Bonneaux, F., “A new approach to aldehydic dextrans,”Polym. Bull. 31:145-149, Springer-Verlag (1993).
Good, A.H., et al., “Identification of Carbohydrate Structures That Bind Human Antiporcine Antibodies: Implications for Discordant Xenografting in Humans,”Transplant. Proc. 24:559-562, Elsevier Science, Inc. (1992).
Inman, J.K., “Thymus-Independant Antigens: The Preparation of Covalent, Hapten-Ficoll Conjugates,”J. Immunol. 114:704-709, The Williams & Wilkins Co., (1975).
Jiang, W., et al., “The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing,”Nature 375:151-155, Macmillan Publishers, Ltd. (1995).
Jing, S-B., et al., “Water absorption of chitosan crosslinked by formaldehyde,”Kichin Kitosan Kenkyu 1:106-107, Shibayama-machi, Chiba (1995).
Kobayashi, M., and Ichishima, E., Application of periodate oxidized glucans to biochemical reactions,J. Carbohydrate Chem. 10:635-644, Marcel Dekker, Inc. (1991).
Kolar, C., et al., “Preparation and Use of Synthetic Blood Group Specific Immunoadsorbents,”Behring Inst. Mitt. 82:94-103, Die Medizinishche Verlagsgesellschaft mbH (1988).
Kumar, T.S., and Rao, K.P., “Biodegradable chitosan microspheres: a potential carrrier for antigens,”Macromolecules—New Front. Proc. IUPAC Int. Symp. Adv. Polm. Sci. Tech. 2:657-661, Allied Publ. Ltd. (1998).
Lagergard, T., et al., Synthesis and Immunological Properties of Conjugates Composed of Group B Streptococcus Type III Capsular Polysaccharide Covalently Bound to Tetanus Toxoid,Infect. Immun. 58:687-694, American Society for Microbiology (1990).
Lett, E., et al., Immunogenicity of Polysaccharides Conjugated to Peptides Containing T- and B-Cell Epitopes,Infect. Immun. 62:785-792, American Society for Microbiology (1994).
Lett, E., et al., “Mucosal Immunogenicity of Polysaccharides Conjugated to a Peptide or Multiple-Antigen Peptide Containing T- and B-Cell Epitopes,”Infect. Immun. 63:2645-2651, American Society for Microbiology (1995).
Lillo, L.E., and Matsuhiro, B., “Chemical modifications of carboxylated chitosan,”Carbohydrate Polym. 34:397-401, Elsevier Science, Ltd. (Dec. 1997).
Lu, C., et al., “Chitin as a solid phase carrier to detect hepatitis B surface antigen,”Shengwu Huaxue Yu Shengwu Wuli Sinzhan 19:454-456, Beijing da xue chu ban ske (1992).
Murata, J.-i., et al., “Synthesis of muramyl dipeptide analogue-glucomannan conjugate and its stimulation activity against macrophage-like cells,”Carbohydrate Polymers 29:111-118, Elsevier Science, Ltd. (Feb. 1996).
Ohya, Y., et al., Synthesis of a MDP Analogue/Chitin Conjugate That Stimulates Cultures Marophages,J. Bioactive&Compatible Polymers 8:351-364, Technomic Publishing Co., Inc. (1993).
Ohya, Y., et al., “Preparation of chitosan and mannan derivatives having carboxylic acid groups by periodate oxidation and their function,”Kichin Kitosan Kenkyu 1:114-115, Shibayama-machi, Chiba (1995).
Ouchi, T., et al., Design of D-glucose analogue of MDP/CM-polysaccharide Conjugates exhibiting macrophage activities, inAnaheim. Book of Abstracts, 209th ACS National Meeting, Anaheim, CA, Apr. 2-6, 1995, Abstract No. 043, P. Cell, American Chemical Society (1995).
Portera, C.A., et al., “Effect of macrophage stimulation on collagen biosynthesis in the healing wound,”Am. Surg. 63:125-131, Southeastern Surgical Congress (Feb. 1997).
Rioux, S., et al., “Evaluation of Protective Efficacy on anActinobacillus pleuropheumoniaeSerotype 1 Lipopolysaccharide-Protein Conjugate in Mice,”Comp. Immun. MIcrobiol. Infect. Dis. 20:63-74, Elsevier Science, Ltd. (Jan. 1997).
Stahl, P.D., The mannose receptor and other macrophage lectins,Curr. Opin. Immunol. 4:49-52, Current Biology, Ltd. (1992).
Biochemistry Labfax, Chambers, J.A.A., and D. Rickwood, eds., Bios Scientific Publishers, Ltd., Oxford, UK, pp. 310,3
Galenica Pharmaceuticals, Inc.
Maier Leigh C.
Sterne Kessler Goldstein & Fox P.L.L.C.
Wilson James O.
LandOfFree
Use of imine-forming polysaccharides as adjuvants and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of imine-forming polysaccharides as adjuvants and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of imine-forming polysaccharides as adjuvants and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3461799